The report comprises the complete economic analysis of pharmaceutical sector in Poland as well as recent data on healthcare sector in the region and contains forecast projections for 2009-2011.
The value data are presented for the total market, pharmacy and hospital segment, Rx, foreign and domestic drugs, generic and innovative medicines, and main ATC categories together with forecasts.
The report offers insights into ongoing trends, taking a closer look at areas of growth and decline. Factors that influence the market, from epidemiology to consumer behaviour, are studied and presented for your thorough understanding of the market. Economic data, such as employment and cost-revenue analysis of the pharmaceutical sector, are also covered.
Our analysis also takes into account the latest changes in reimbursement and legislation (latest and expected). The impact of global financial crisis has also been analysed and taken into consideration in the forecasts provided for the size of the Polish pharmaceutical and healthcare market by the PMR team of pharmaceutical analysts and economists.
If you are looking for:
detailed information on legal environment together with most important changes in the “minor” and “major” amendments to the Pharmaceutical Act, analysis of changes is Act on Healthcare Services Financed from Public Funds
analysis of latest novelisations of reimbursement lists and their impact on the market
profiles of largest players active on pharma market
strategic key data
data needed for market entry
description of epidemiologic and demographic trends
(0 items)
